rs111917407 - GLB1
Magnitude 2.2 · 1 study on file
Reported associations
-
Genome-Wide Integration of Genetic and Genomic Studies of Atopic Dermatitis: Insights into Genetic Architecture and Pathogenesis. - The Journal of investigative dermatology (2022) · Chen Y, Chen W · PubMed 35577104
Atopic dermatitis (AD) is a common heterogeneous, chronic, itching, and inflammatory skin disease. Genetic studies have identified multiple AD susceptibility genes. However, the genetic architecture of AD has not been elucidated. In this study, we conducted a large-scale meta-analysis of AD (35,647 cases and 1,013,885 controls) to characterize the genetic basis of AD. The heritability of AD in different datasets varied from 0.6 to 7.1%. We identified 31 previously unreported genes by integrating multiomics data. Among the 31 genes, MCL1 was identified as a potential treatment target for AD by mediating gene‒drug interactions. Tissue enrichment analyses and phenome-wide association study provided strong support for the role of the hemic and immune systems in AD. Across 1,207 complex trait
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
Atopic dermatitis genetic risk management Moderate
Genetic predisposition to atopic dermatitis enables early professional intervention and personalized disease prevention strategies.
Discuss genetic risk with dermatologist; explore preventive skincare and early intervention options.
Screening
-
Atopic dermatitis symptom awareness Moderate
rs111917407 T allele strongly associates with increased atopic dermatitis susceptibility, warranting proactive disease monitoring.
Monitor for itching, redness, dryness, skin barrier changes; note timing and potential environmental triggers.